Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

A better understanding of the anti-SARS-CoV-2 immune response is necessary to finely evaluate commercial serological assays but also to predict protection against reinfection and to help the development of vaccines. For this reason, we monitored the anti-SARS-CoV-2 antibody response in infected pati...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-10-01
coleção:	Frontiers in Microbiology
Assuntos:	SARS-CoV-2 COVID-19 spike nucleocapsid neutralizing antibodies vaccine
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fmicb.2020.584251/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!